Physicians and pharmacists: collaboration to improve the quality of prescriptions in primary care in Mexico

被引:6
作者
Mino-Leon, Dolores [1 ]
Reyes-Morales, Hortensia [2 ]
Jasso, Luis [3 ]
Vladislavovna Douvoba, Svetlana [4 ]
机构
[1] Secretaria Salud Mexico, Inst Geriatria, Mexico City, DF, Mexico
[2] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Direcc Determinantes & Retos Sistemas Salud, Cuernavaca, Morelos, Mexico
[3] Secretaria Salud Mexico, Hosp Infantil Mexico, Mexico City, DF, Mexico
[4] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Mexico City, DF, Mexico
关键词
Family doctors; Intervention; Mexico; Patient safety; Prescription errors; ADVERSE DRUG EVENTS; ERRORS; TRIAL; INTERVENTION; MANAGEMENT; HYPERTENSION; EDUCATION; PROGRAM;
D O I
10.1007/s11096-012-9632-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Inappropriate prescription is a relevant problem in primary health care settings in Mexico, with potentially harmful consequences for patients. Objective To evaluate the effectiveness of incorporating a pharmacist into primary care health team to reduce prescription errors for patients with diabetes and/or hypertension. Setting One Family Medicine Clinic from the Mexican Institute of Social Security in Mexico City. Method A "pharmacotherapy intervention" provided by pharmacists through a quasi experimental (before-after) design was carried out. Physicians who allowed access to their diabetes and/or hypertensive patients' medical records and prescriptions were included in the study. Prescription errors were classified as "filling", "clinical" or "both". Descriptive analysis, identification of potential drug-drug interactions (pD-DI), and comparison of the proportion of patients with prescriptions with errors detected "before" and "after" intervention were performed. Main outcome measure Decrease in the proportion of patients who received prescriptions with errors after the intervention. Results Pharmacists detected at least one type of error in 79 out of 160 patients. Errors were "clinical", "both" and "filling" in 47, 21 and 11 of these patient's prescriptions respectively. Predominant errors were, in the subgroup of patient's prescriptions with "clinical" errors, pD-DI; in the subgroup of "both" errors, lack of information on dosing interval and pD-DI; and in the "filling" subgroup, lack of information on dosing interval. The pD-DI caused 50 % of the errors detected, from which 19 % were of major severity. The impact of the correction of errors post-intervention was observed in 19 % of patients who had erroneous prescriptions before the intervention of the pharmacist (49.3-30.3 %, p < 0.05). Conclusion The impact of the intervention was relevant from a clinical point of view for the public health services in Mexico. The implementation of early warning systems of the most widely prescribed drugs is an alternative for reducing prescription errors and consequently the risks they may cause.
引用
收藏
页码:475 / 480
页数:6
相关论文
共 24 条
  • [1] A Prospective Trial of a Clinical Pharmacy Intervention in a Primary Care Practice in a Capitated Payment System
    Altavela, Jeanette L.
    Jones, Matt K.
    Ritter, Merrilee
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (09): : 831 - 843
  • [2] Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices
    Avery, Anthony J.
    Rodgers, Sarah
    Cantrill, Judith A.
    Armstrong, Sarah
    Elliott, Rachel
    Howard, Rachel
    Kendrick, Denise
    Morris, Caroline J.
    Murray, Scott A.
    Prescott, Robin J.
    Cresswell, Kathrin
    Sheikh, Aziz
    [J]. TRIALS, 2009, 10
  • [3] Beney J., 2000, COCHRANE DB SYST REV, pCD000336, DOI [10.1002/14651858.cd000336, DOI 10.1002/14651858.CD000336]
  • [4] Reducing medication errors and increasing patient safety: Case studies in clinical pharmacology
    Benjamin, DM
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (07) : 768 - 783
  • [5] An evaluation of a continuing medical education program for primary care services in the hypoglycemic agent's prescription in diabetes mellitus type 2
    Castro-Rios, Angelica
    Reyes-Morales, Hortensia
    Perez-Cuevas, Ricardo
    [J]. SALUD PUBLICA DE MEXICO, 2008, 50 : S445 - S452
  • [6] Adverse drug events in ambulatory care
    Gandhi, TK
    Weingart, SN
    Borus, J
    Seger, AC
    Peterson, J
    Burdick, E
    Seger, DL
    Shu, K
    Federico, F
    Leape, LL
    Bates, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (16) : 1556 - 1564
  • [7] Outpatient prescribing errors and the impact of computerized prescribing
    Gandhi, TK
    Weingart, SN
    Seger, AC
    Borus, J
    Burdick, E
    Poon, EG
    Leape, LL
    Bates, DW
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (09) : 837 - 841
  • [8] Glazier RH, 1998, CAN MED ASSOC J, V158, P1037
  • [9] Incidence and preventability of adverse drug events among older persons in the ambulatory setting
    Gurwitz, JH
    Field, TS
    Harrold, LR
    Rothschild, J
    Debellis, K
    Seger, AC
    Cadoret, C
    Garber, L
    Kelleher, M
    Bates, DW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (09): : 1107 - 1116
  • [10] Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study
    Howard, RL
    Avery, AJ
    Howard, PD
    Partridge, M
    [J]. QUALITY & SAFETY IN HEALTH CARE, 2003, 12 (04): : 280 - 285